| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1921969 | Parkinsonism & Related Disorders | 2009 | 6 Pages |
Abstract
Levodopa use in parkinsonian patients is associated with reduced vascular risk factors. In causal terms this finding might be attributed to the inhibitory action of levodopa-derived dopamine on the sympathetic nervous system.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Giulio Scigliano, Gabriele Ronchetti, Floriano Girotti, Massimo Musicco,